Laurus Labs Limited — Capital/Financing Update 2025

Jun 26, 2025

June 26, 2025

==> picture [190 x 81] intentionally omitted <==

ToThe Corporate Relations DepartmentBSE LimitedPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001Code: 540222	ToThe Listing DepartmentNational Stock Exchange of India Ltd.,Exchange Plaza,Bandra Kurla Complex, Bandra (E),Mumbai – 400 051Code: LAURUSLABS

Sub: Update on proposed investment in Laurus Bio Private Limited under Regulation 30(7) of SEBI (LODR) Regulations, 2015

Ref: Our intimation letter dated 06[th] December, 2024

Dear Sir / madam,

In continuation to our letter dated December 06, 2024 with regard to the investment in Laurus Bio Private Limited (“Laurus Bio”) (a subsidiary of the Company) and as per Regulation 30(7) of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has invested INR 39,99,93,608.28/- (Indian Rupees Thirty Nine Crores Ninety Nine Lakhs Ninety Three Thousand Six Hundred and Eight and Paise Twenty Eight Only) and acquired 15,414 (Fifteen Thousand Four Hundred and Fourteen) Series A2 Compulsorily Convertible Preference Shares of Laurus Bio at face value of INR 100/- and premium of INR 25,850.02/- each aggregating to an amount of INR 39,99,93,608.28/- (Rupees Thirty Nine Crores Ninety Nine Lakhs Ninety Three Thousand Six Hundred and Eight and Paise Twenty Eight Only) by way of Private Placement cum Preferential Allotment basis.

Please take the above information on record.

Yours faithfully,

For Laurus Labs Limited

VENKATESWAR Digitally signed by VENKATESWAR REDDY REDDY GOGIREDDY GOGIREDDY Date: 2025.06.26 11:39:44 +05'30'

G. Venkateswar Reddy

Company Secretary & Compliance Officer

==> picture [453 x 76] intentionally omitted <==